Re:Trial results for new lung cancer drug are 'off the charts'
by ilya_m on Friday May 31, 2024 @07:45PM
(#40541423)
>>>>Even after 60.2 months of follow-up, the median progression-free survival has not yet been reached [1]
> This sounds awful? Or contradictory at best?
No, quite amazing. At 5 years more than 50% of participants are progression-free. That's indeed off the charts for a metastatic lung cancer.
Re:Trial results for new lung cancer drug are 'off the charts'
by fredophile on Saturday June 01, 2024 @12:17AM
(#40542829)
I believe the median progression-free survival is the length of time where 50% of people are still free from progression. The numbers you mentioned would mean that we don't know how long that is for this treatment but it's definitely longer than 5 years. That sounds pretty good depending on the type of cancer and stage when treatment started.
>>>>Five-year data indicate a significant progression-free survival benefit, with 60% of patients free of progression.
So far im with you.
>>>>Even after 60.2 months of follow-up, the median progression-free survival has not yet been reached [1]
This sounds awful? Or contradictory at best?